Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze EYPT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate EYPT investment potential.

What is EYPT stock price today?

Get real-time EYPT stock price, historical data, and price charts on Financhill. Track EYPT performance with our advanced analysis tools.

Is EYPT a good investment?

Evaluate EYPT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy EYPT stock?

To buy EYPT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of EYPT?

View detailed market capitalization data and company valuation metrics for EYPT on our comprehensive analysis page.

What is the P/E ratio of EYPT?

Use our fundamental analysis tools to view EYPT P/E ratio and compare valuation metrics with industry peers.

What are EYPT earnings?

View EYPT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

EyePoint Pharmaceuticals, Inc. Stock Predictions

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

EYPT
EyePoint Pharmaceuticals, Inc.

Last Price:

$16.72

Seasonality Move:

16.53%

7 Day Trial

ALL ACCESS PASS

$ 7

This AI Layer Just Raised Its Share Price

EyePoint Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, EyePoint Pharmaceuticals, Inc. has on average historically risen by 18% based on the past 20 years of stock performance.
EyePoint Pharmaceuticals, Inc. has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
Is EyePoint Pharmaceuticals, Inc. Stock Undervalued?

The current EyePoint Pharmaceuticals, Inc. [EYPT] share price is $16.72. The Score for EYPT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will EyePoint Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, EyePoint Pharmaceuticals, Inc. has on average historically risen by 18% based on the past 20 years of stock performance.

EyePoint Pharmaceuticals, Inc. Stock Rating

Buy

EyePoint Pharmaceuticals, Inc. (EYPT) is a Buy

Is EyePoint Pharmaceuticals, Inc. overpriced?

EyePoint Pharmaceuticals, Inc. has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%

EyePoint Pharmaceuticals, Inc. Stock Price History

Is EYPT stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

eyepointpharma.com

52-Week Data

52-Week High:

17.00

52-Week Low:

3.91

Prediction Charts

Market Cap:

1.4B

Price in USD:

16.72

Volume:

Beta:

1.89

Technical Analysis

SMA50:

12.97

SMA100:

12.29

SMA200:

9.68

52-Wk Change:

96.94%

Stock Predictions

Is EyePoint Pharmaceuticals, Inc. stock public?

Yes, EyePoint Pharmaceuticals, Inc. is a publicly traded company.
What is the EyePoint Pharmaceuticals, Inc. stock quote today?

The EyePoint Pharmaceuticals, Inc. stock price is 16.72 USD today.
How to buy EyePoint Pharmaceuticals, Inc. stock online?

You can buy EyePoint Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	11.30	11.59	12.04	11.30
Nov-17	11.69	13.14	13.29	11.55
Nov-18	13.14	13.94	14.55	12.95
Nov-19	13.80	14.28	14.64	13.70
Nov-20	14.49	13.66	14.67	13.55
Nov-21	13.63	13.68	13.97	13.43
Nov-24	13.84	14.39	14.49	13.75
Nov-25	14.40	14.74	14.76	13.86
Nov-26	14.50	14.79	14.96	14.26
Nov-28	14.81	14.83	14.95	14.64
Dec-1	14.66	14.26	14.69	14.21
Dec-2	14.36	13.69	14.46	13.61
Dec-3	13.78	14.52	14.60	13.78
Dec-4	14.52	16.72	17.00	14.40

EyePoint Pharmaceuticals, Inc. Earnings

EyePoint Pharmaceuticals, Inc. Earnings Report: Per Share EyePoint Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

EyePoint Pharmaceuticals, Inc. Forecast Revenue Growth

EyePoint Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.85 per share, and an increase next year of $0.25 per share.

* EyePoint Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.